A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects
Clinical trial NCT03836599 · COMPLETED
Trial details
- NCT number
- NCT03836599
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2019-04-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.